The global NGS services market size is anticipated to around USD 3.0 billion by 2026, this market is anticipated to grow with 14.1% CAGR during the forecast time period. Next-generation sequencing technology is progressively leveraged for both conventional and non-conventional applications to advance speedy and comprehensive insights at a genomic level. This is mainly owing to continuous developments in ancillary protocols, automation, services, and analytical solutions in this field. This, in turn, has provided healthy development prospects for application of NGS in clinical workflows.
Rising need for robust sequencing-based diagnostics has resulted in the beginning of new seq-technologies, ranging from high-throughput sequencers to portable units. This has stimulated the trend of clinical NGS in over the coming years. Such as, in March 2018, ARUP Laboratories and IDbyDNA, Inc. launchedExplify Respiratory, an NGS test for respiratory infections, to assist physicians in screening patients with pneumonia and other respiratory illnesses.
Download Report Sample Pages For Better Understanding@ https://www.acumenresearchandconsulting.com/request-sample/966
The market leader, Illumina, has launched the Illumina Propel Certification Program (CSPro) to establish a partnership between the business and laboratories. GENEWIZ, Inc. received Illumina’s CSPro certification for NGS and became a member of the elite group of Illumina genomics service providers in December 2013. Personalis additional provider, which receive the CSPro Certifications in May 2013.
VIEW DETAIL REPORT WITH COMPLETE TOC@ https://www.acumenresearchandconsulting.com/ngs-services-market
Most of the service providers employ platforms from PacBio, Illumina, and Oxford Nanopore Technologies. They use these technologies in-house to serve their clients by offering projects with high quality and within the shortest timelines. There are also few products, which are no longer commercially available, for instance products from 454 Life Sciences.
Some products are still under growth, for instance, Ion Torrent’s semiconductor sequencing and SOLiD platform. Though, these products are not as extensively accepted as those offered by Illumina. Illumina introduced new flagship product NovaSeq 6000, which can produce three to forty eight human genomes per run in March 2017.
Data generated through genome sequencing is considered an efficient prognostic and diagnostic tool to help clinicians in recognising specific features in each patient. This, in turn, aids in delivering modified therapies to patients, therefore improving patient outcome This parameters is expected to boost need for NGS-based diagnostics during the forecasted period.
Some of the key issues faced by end users in the NGS services industry are implementing large-scale data analysis and analytical challenges while conducting single-cell seq. However, producers are continually strategizing their research and development in order to address these limitation and increase the scope of NGS services.
The global NGS services market is segmented into service type, workflow, end-user and region.On the basis of service type, the global NGS services market is segmented into human genome sequencing, single cell sequencing, microbial genome-based sequencing, gene regulation services, animal & plant sequencing and other sequencing services. Gene Regulation Services is further bifurcated into small RNA sequencing, chip sequencing, and other gene regulation-based services. On the basis of workflow, the global NGS services market is segmented into pre-sequencing, sequencing, and data analysis. On the basis of the cause the global NGS services market is segmented into universities & other research entities, hospitals & clinics, pharma & biotech entities, and others. On the basis of the end-user the global NGS services market is segmented into hospitals, clinics, and others. The hospital sub-segment is further bifurcated into inpatient and outpatient. On the basis of region the global NGS services market is segmented into Latin America, Europe, Asia Pacific, North America, and Middle East & Africa.
Market companies are concentrating on implementing new strategies for instance regional expansion, partnerships, mergers and acquisitions, new product launches, and distribution agreements to surge their revenue share. And also, growing R&D investments paired with technical advancements to commercialize highly efficient products are expected to offer huge growth opportunities for industry participants. Some of the main businesses present in the NGS services market are GENEWIZ Germany GmbH,Illumina, Inc.,Novogene Corporation,abm Inc.,Veritas Genetics,Quest Diagnostics,Gene by Gene, ARUP Laboratories,BGI, and Lucigen. Significant strategic initiatives undertaken by global businesses include partnerships, new product launch, acquisitions.
INQUIRY BEFORE BUYING@ https://www.acumenresearchandconsulting.com/inquiry-before-buying/966
The report is readily available and can be dispatched immediately after payment confirmation.
Buy this premium research report - https://www.acumenresearchandconsulting.com/buy-now/0/966
Would like to place an order or any question, please feel free to contact at firstname.lastname@example.org | +1 407 915 4157